CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.23 HKD | -0.16% |
|
+17.11% | +21.44% |
| 04-24 | China Resources Pharmaceutical Group Limited Announces Change of Company Secretary | CI |
| 04-18 | China Resources Pharma Unit Issues 3 Billion Yuan Bonds | MT |
| Sales 2024 * | 282B 36.05B 2,866B | Sales 2025 * | 313B 40.06B 3,184B | Capitalization | 39.14B 5.01B 398B |
|---|---|---|---|---|---|
| Net income 2024 * | 4.58B 586M 46.57B | Net income 2025 * | 5.12B 656M 52.11B | EV / Sales 2024 * | 0.26 x |
| Net Debt 2024 * | 33.07B 4.23B 336B | Net Debt 2025 * | 31.59B 4.04B 321B | EV / Sales 2025 * | 0.23 x |
| P/E ratio 2024 * |
8.72
x | P/E ratio 2025 * |
7.73
x | Employees | 72,986 |
| Yield 2024 * |
2.64% | Yield 2025 * |
2.96% | Free-Float | 27.95% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.16% | ||
| 1 week | +17.11% | ||
| Current month | +22.64% | ||
| 1 month | +32.55% | ||
| 3 months | +27.93% | ||
| 6 months | +29.25% | ||
| Current year | +21.44% |
1 week
5.23
6.30
1 month
4.626.30
Current year
4.456.30
1 year
4.457.75
3 years
3.188.13
5 years
3.1810.58
10 years
3.1813.16
| Managers | Title | Age | Since |
|---|---|---|---|
Xiao Song Bai
CEO | Chief Executive Officer | 52 | 13/01/22 |
Rong Hui Deng
DFI | Director of Finance/CFO | 46 | 12/06/23 |
Yue Wei Han
CHM | Chairman | 56 | 21/10/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Rui Fang Jiao
BRD | Director/Board Member | 47 | 13/01/22 |
Ting Mei Fu
BRD | Director/Board Member | 57 | 31/05/16 |
Ke Jian Zhang
BRD | Director/Board Member | 68 | 19/06/16 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.92% | 4 M€ | -27.92% | ||
| 0.52% | 2 M€ | -12.08% | - | |
| 0.12% | 4 M€ | -11.56% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/05/24 | 6.23 | -0.16% | 13 553 368 |
| 13/05/24 | 6.24 | +5.94% | 26,509,000 |
| 10/05/24 | 5.89 | +5.56% | 27,839,980 |
| 09/05/24 | 5.58 | +5.48% | 27,866,820 |
| 08/05/24 | 5.29 | -0.56% | 11,080,780 |
Delayed Quote Hong Kong S.E., May 14, 2024 at 09:08 am
More quotes
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally engaged in the research and development, manufacturing, distribution and retail of pharmaceutical and other healthcare products. The Company mainly operates through three segments. Pharmaceutical Manufacturing segment is engaged in the research and development, manufacturing and sale of pharmaceutical and other healthcare products. Pharmaceutical Distribution segment is engaged in the provision of distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. Pharmaceutical Retail segment is involved in the operation of retail pharmacies in China and Hongkong.
Sector
Pharmaceuticals
Calendar
21/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
6.24
HKD
Average target price
7.382
HKD
Spread / Average Target
+18.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +21.44% | 5.02B | |
| +29.28% | 682B | |
| +30.47% | 586B | |
| -3.15% | 364B | |
| +17.54% | 327B | |
| +3.68% | 285B | |
| +16.23% | 240B | |
| +9.96% | 209B | |
| -8.34% | 203B | |
| +7.49% | 165B |
- Stock Market
- Equities
- 3320 Stock
